Moleculera Biosciences, Inc.
Oklahoma City
About Moleculera Biosciences, Inc.
Precision medicine focused on immune-mediated neuropsychiatric, cardiovascular, long-COVID, and neurodegenerative disorders
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $6.7M
- Last round: Grant (Oct 2024)
- Website: moleculeralabs.com
- Phone: 14052395250
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/moleculera-biosciences-inc-85924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.